- FILTERS Advanced
- Product Type
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- CE / IVD
- Clone ID
- Supplier
- EXCLUDE FILTERS
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- Clone ID
- Supplier
| Name | Art no | Species Reactivity | Application | Conjugation | Clone | Size | Price |
|---|---|---|---|---|---|---|---|
|
TA804162S
|
human
|
WB
|
|
OTI3C2
|
30 µl
|
||
|
982202
|
human
|
FC
|
APC
|
HI10a
|
500 µL
|
||
|
983302
|
human
|
FC
|
APC
|
104D2
|
500 µL
|
||
|
982604
|
human
|
FC
|
APC
|
ICRF44
|
500 µL
|
||
|
982506
|
human
|
FC
|
APC
|
M5E2
|
500 µL
|
||
|
980104
|
human
|
FC
|
APC
|
3G8
|
500 µL
|
||
|
982406
|
human
|
FC
|
APC
|
HIB19
|
500 µL
|
||
|
980206
|
human
|
FC
|
APC
|
2H7
|
500 µL
|
||
|
983406
|
human
|
FC
|
APC
|
CD28.2
|
500 µL
|
||
|
983902
|
human
|
FC
|
APC
|
WM53
|
500 µL
|
||
|
980812
|
human
|
FC
|
APC
|
SK3
|
500 µL
|
||
|
982304
|
human
|
FC
|
APC
|
HI30
|
500 µL
|
||
|
983102
|
human
|
FC
|
APC
|
UCHL1
|
500 µL
|
||
|
981204
|
human
|
FC
|
APC
|
5.1H11
|
500 µL
|
||
|
982702
|
human
|
FC
|
APC
|
CD7-6B7
|
500 µL
|
||
|
980904
|
human
|
FC
|
APC
|
SK1
|
500 µL
|
||
|
980406
|
human
|
FC
|
APC
|
L243
|
500 µL
|
||
|
982314
|
human
|
FC
|
APC/Fire750
|
HI30
|
500 µL
|
||
|
980412
|
human
|
FC
|
APC/Fire750
|
L243
|
500 µL
|
||
|
31-1149-00
|
human
|
IHC, WB
|
Unconjugated
|
RM268
|
100 uL
|
||
|
31-1268-00
|
human
|
IHC, WB
|
Unconjugated
|
RM382
|
100 uL
|
||
|
206-B06-63R-100
|
human
|
|
|
|
100 ug
|
||
|
206-B10-63R-100
|
human
|
|
|
|
100 ug
|
||
|
Ab00992-23.0
|
human
|
ELISA
|
Unconjugated
|
Fab 100
|
200 µg
|
||
|
Ab00535-10.6
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
100 µg
|
||
|
Ab00535-1.1
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
200 µg
|
||
|
Ab00535-2.0
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
200 µg
|
||
|
Ab00535-23.0-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
1 mg
|
||
|
Ab00535-1.1-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
1 mg
|
||
|
Ab00535-10.0-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
1 mg
|
||
|
Ab00535-10.6-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
500 µg
|
||
|
Ab00535-10.3
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
200 µg
|
||
|
Ab00535-2.0-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
1 mg
|
||
|
Ab00535-23.0
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
200 µg
|
||
|
Ab00535-10.3-BT
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
1 mg
|
||
|
Ab00535-10.0
|
human
|
Block, FC
|
Unconjugated
|
hu1124 (Efalizumab)
|
200 µg
|
||
|
Ab00118-23.0
|
human
|
FC
|
Unconjugated
|
OX108
|
200 µg
|
||
|
Ab00118-1.1-BT
|
human
|
FC
|
Unconjugated
|
OX108
|
1 mg
|
||
|
Ab00118-1.1
|
human
|
FC
|
Unconjugated
|
OX108
|
200 µg
|
||
|
Ab00118-23.0-BT
|
human
|
FC
|
Unconjugated
|
OX108
|
1 mg
|
||
|
Ab00993-10.0
|
human
|
WB
|
Unconjugated
|
MU375
|
200 µg
|
||
|
Ab00787-23.0
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
200 µg
|
||
|
Ab00787-13.0-BT
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
1 mg
|
||
|
Ab00787-10.6
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
100 µg
|
||
|
Ab00787-10.6-BT
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
500 µg
|
||
|
Ab00787-23.0-BT
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
1 mg
|
||
|
Ab00787-13.0
|
human, monkey
|
Block, ELISA, FC, IP, IHC
|
Unconjugated
|
5D12
|
200 µg
|
||
|
Ab00447-1.4-BT
|
human
|
Block, FC, WB
|
Unconjugated
|
hu5c8 (Ruplizumab)
|
1 mg
|
||
|
Ab00447-1.1
|
human
|
Block, FC, WB
|
Unconjugated
|
hu5c8 (Ruplizumab)
|
200 µg
|
||
|
Ab00447-2.0-BT
|
human
|
Block, FC, WB
|
Unconjugated
|
hu5c8 (Ruplizumab)
|
1 mg
|